Consolidated Statements of Shareholders' Equity - USD ($) $ in Thousands |
Common Stock
2025 Underwritten Public Offering
|
Common Stock
Private Placement 2024
|
Common Stock
Private Placement 2025
|
Common Stock |
Additional Paid-in Capital
2025 Underwritten Public Offering
Pre-funded warrants
|
Additional Paid-in Capital
2025 Underwritten Public Offering
|
Additional Paid-in Capital
Private Placement 2024
|
Additional Paid-in Capital
Private Placement 2025
|
Additional Paid-in Capital |
Accumulated Other Comprehensive Income (Loss) |
Accumulated Deficit |
2025 Underwritten Public Offering
Pre-funded warrants
|
2025 Underwritten Public Offering |
Private Placement 2024 |
Private Placement 2025 |
Pre-funded warrants |
Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance beginning at Jun. 30, 2024 | $ 53 | $ 450,473 | $ (79) | $ (329,444) | $ 121,003 | ||||||||||||
| Balance beginning (in shares) at Jun. 30, 2024 | 53,245,824 | ||||||||||||||||
| Gross proceeds from issuance of common stock for cash | $ 25 | $ 1 | $ 1 | $ 21,089 | $ 76,169 | $ 5,999 | $ 4,209 | $ 21,089 | $ 76,194 | $ 6,000 | $ 4,210 | ||||||
| Gross proceeds from issuance of common stock for cash (in shares) | 24,940,769 | 1,500,000 | 1,295,383 | ||||||||||||||
| Commissions and other offering costs | (546) | (546) | |||||||||||||||
| Issuance of common stock upon exercise of stock options | $ 1 | 1,395 | $ 1,396 | ||||||||||||||
| Issuance of common stock upon exercise of stock options (in shares) | 488,742 | 488,742 | |||||||||||||||
| Share-based compensation | 7,121 | $ 7,121 | |||||||||||||||
| Cashless exercise of pre-funded warrants | $ 6 | (6) | |||||||||||||||
| Cashless exercise of pre-funded warrants (in shares) | 5,525,267 | 5,525,267 | |||||||||||||||
| Other comprehensive (loss) income | 72 | 72 | |||||||||||||||
| Net loss | (74,412) | (74,412) | |||||||||||||||
| Balance ending at Jun. 30, 2025 | $ 87 | 565,903 | (7) | (403,856) | $ 162,127 | ||||||||||||
| Balance ending (in shares) at Jun. 30, 2025 | 86,995,985 | 86,995,985 | |||||||||||||||
| Issuance of common stock upon exercise of stock options | $ 1 | 1,797 | $ 1,798 | ||||||||||||||
| Issuance of common stock upon exercise of stock options (in shares) | 825,953 | 825,953 | |||||||||||||||
| Issuance of common stock upon vesting of restricted stock units (in shares) | 360,165 | ||||||||||||||||
| Share-based compensation | 14,460 | $ 14,460 | |||||||||||||||
| Cashless exercise of pre-funded warrants | $ 8 | (8) | |||||||||||||||
| Cashless exercise of pre-funded warrants (in shares) | 8,223,879 | 8,223,879 | |||||||||||||||
| Other comprehensive (loss) income | (112) | (112) | |||||||||||||||
| Net loss | (77,586) | (77,586) | |||||||||||||||
| Balance ending at Jun. 30, 2026 | $ 96 | $ 582,152 | $ (119) | $ (481,442) | $ 100,687 | ||||||||||||
| Balance ending (in shares) at Jun. 30, 2026 | 96,405,982 | 96,405,982 |
| X | ||||||||||
- Definition Number of shares issued upon exercise of pre-funded warrants. No definition available.
|
| X | ||||||||||
- Definition Value of stock issued upon exercise of pre-funded warrants No definition available.
|
| X | ||||||||||
- Definition Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Number of share options (or share units) exercised during the current period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Value of stock issued as a result of the exercise of stock options. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|